Prepulse inhibition is associated with attention, processing speed, and 123I-FP-CIT SPECT in Parkinson's Disease

Journal of Parkinson's Disease

Volumn 4, Issue 1, 2014, Pages 77-87

  Zoetmulder, Marielle ^a,b   Biernat, Heidi B ^a   Nikolic, Miki ^b   Korbo, Lise ^a   Friberg, Lars ^a   Jennum, Poul J ^b  

^a BISPEBJERG HOSPITAL   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Dopamine system; Parkinson's disease; Prepulse inhibition; SPECT

Indexed keywords

DOPAMINE TRANSPORTER; IODINE 123;

ADULT; AGED; ARTICLE; ATTENTION; BRAIN DYSFUNCTION; CAUDATE NUCLEUS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; NERVOUS SYSTEM PARAMETERS; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PREPULSE INHIBITION; PRIORITY JOURNAL; PROCESSING SPEED; PUTAMEN; SENSORY GATING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

DOPAMINE SYSTEM; PARKINSON'S DISEASE; PREPULSE INHIBITION; SPECT;

AGED; ATTENTION; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; INHIBITION (PSYCHOLOGY); MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; SENSORY GATING; STARTLE REACTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 84899013151     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-130307     Document Type: Article

References (72)

1. Hoffman EL, & Bennett FC (1990) Birth weight less than 800 grams: Changing outcomes and influences of gender and gestation number. Pediatrics, 86, 27-34 (Pubitemid 20198454)
2. Braff DL, Geyer MA, & Swerdlow NR (2001) Human studies of prepulse inhibition of startle: Normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl), 156, 234-258 (Pubitemid 32705488)
3. Braff DL, & Geyer MA (1990) Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry, 47, 181-188 (Pubitemid 20058094)
4. Brandt GN, & Bonelli RM (2008) Structural neuroimaging of the basal ganglia in schizophrenic patients: A review.Wien Med Wochenschr, 158, 84-90 (Pubitemid 351373923)
5. Howes OD, & Kapur S (2009) The dopamine hypothesis of schizophrenia: Version III-the final common pathway. Schizophr Bull, 35, 549-562
6. Castellanos FX, Fine EJ, Kaysen D, Marsh WL, Rapoport JL, & Hallett M (1996) Sensorimotor gating in boys with Tourette's syndrome and ADHD: Preliminary results. Biol Psychiatry, 39, 33-41 (Pubitemid 26022681)
7. Plessen KJ, Bansal R, & Peterson BS (2009) Imaging evidence for anatomical disturbances and neuroplastic compensation in persons with Tourette syndrome. J Psychosom Res, 67, 559-573
8. Swerdlow NR, Paulsen J, Braff DL, Butters N, Geyer MA, & Swenson MR (1995) Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J Neurol Neurosurg Psychiatry 58, 192-200
9. Kienast T, & Heinz A (2006) Dopamine and the diseased brain. CNS Neurol Disord Drug Targets, 5, 109-131 (Pubitemid 43796630)
10. Brooks S, Higgs G, Jones L, & Dunnett SB (2012) Longitudinal analysis of the behavioural phenotype in Hdh(CAG)150 Huntington's disease knock-in mice. Brain Res Bull, 88, 182-188
11. Fuchs J, Mueller JC, Lichtner P, Schulte C, Munz M, Berg D, et al. (2009) The transcription factor PITX3 is associated with sporadic Parkinson's disease. Neurobiol Aging 30, 731-738
12. Hwang DY, Hong S, Jeong JW, Choi S, Kim H, Kim J,&Kim KS (2009) Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons. J Neurochem 111, 1202-1212
13. Saijo K,Winner B, CarsonCT, Collier JG, Boyer L, Rosenfeld MG, et al. (2009)ANurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammationinduced death. Cell, 137, 47-59
14. Johnson MM, Michelhaugh SK, Bouhamdan M, Schmidt CJ, &BannonMJ(2011) TheTranscription FactorNURR1Exerts Concentration-Dependent Effects on Target Genes Mediating Distinct Biological Processes. Front Neurosc, 5, 135
15. Ohgake S, Shimizu E, Hashimoto K, Okamura N, Koike K, Koizumi H, et al. (2009) Dopaminergic hypofunctions and prepulse inhibition deficits in mice lacking midkine. Prog Neuropsychopharmacol Biol Psychiatry, 33, 541-546
16. Vuillermot S, Feldon J, & Meyer U (2011) Relationship between sensorimotor gating deficits and dopaminergic neuroanatomy in Nurr1-deficient mice. Exp Neurol 232, 22-32
17. Kodsi MH, & Swerdlow NR (1995) Prepulse inhibition in the rat is regulated by ventral and caudodorsal striato-pallidal circuitry. Behav Neurosci, 109, 912-928
18. Koch M, Fendt M, & Kretschmer BD (2000) Role of the substantia nigra pars reticulata in sensorimotor gating, measured by prepulse inhibition of startle in rats. Behav Brain Res, 117, 153-162
19. Baldan Ramsey LC, Xu M, Wood N, & Pittenger C (2011) Lesions of the dorsomedial striatum disrupt prepulse inhibition. Neuroscience, 180, 222-228
20. Vuillermot S, Feldon J, & Meyer U (2011) Relationship between sensorimotor gating deficits and dopaminergic neuroanatomy in Nurr1-deficient mice. Exp Neurol 232, 22-32
21. Jellinger KA (2009) Formation and development of Lewy pathology:Acritical update. J Neurol, 256(Suppl 3), 270-279
22. Le W, Pan T, Huang M, Xu P, Xie W, Zhu W, et al. (2008) Decreased NURR1 gene expression in patients with Parkinson's disease. J Neurol Sci, 273, 29-33
23. Liu H,Wei L, Tao Q, Deng H, Ming M, Xu P, & LeW(2012) Decreased NURR1 and PITX3 gene expression in Chinese patients with Parkinson's disease. Eur J Neurol 19(6), 870-875
24. Le WD, Xu P, Jankovic J, Jiang H, Appel SH, Smith RG, & Vassilatis DK (2003) Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet 33, 85-89 (Pubitemid 36068688)
25. Chu Y, Le W, Kompoliti K, Jankovic J, Mufson EJ, & Kordower JH (2006) Nurr1 in Parkinson's disease and related disorders. J Comp Neurol 494, 495-514 (Pubitemid 41790998)
26. Grimes DA, Han F, Panisset M, Racacho L, Xiao F, Zou R, et al. (2006) Translated mutation in the Nurr1 gene as a cause for Parkinson's disease. Mov Disord, 21, 906-909 (Pubitemid 44184588)
27. Sleiman PM, Healy DG, Muqit MM, Yang YX, Van Der Brug M, Holton JL, et al. (2009) Characterisation of a novel NR4A2 mutation in Parkinson's disease brain. Neurosci Lett, 457, 75-79
28. Iranzo A, Valldeoriola F, Lomena F, Molinuevo JL, Serradell M, Salamero M, et al. (2011) Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: A prospective study. Lancet Neurol, 10, 797-805
29. Crowell AL, Ryapolova-Webb ES, Ostrem JL, Galifianakis NB, Shimamoto S, Lim DA, & Starr PA (2012) Oscillations in sensorimotor cortex inmovement disorders: An electrocorticography study. Brain, 135, 615-630
30. Tessa C, Lucetti C, Diciotti S, Paoli L, Cecchi P, Giannelli M, et al. (2012) Hypoactivation of the primary sensorimotor cortex in de novo Parkinson's disease : A motor fMRI study under controlled conditions. Neuroradiology, 54, 261-268
31. Dujardin K, Degreef JF, Rogelet P, Defebvre L, & Destee A (1999) Impairment of the supervisory attentional system in early untreated patients with Parkinson's disease. J Neurol, 246, 783-788 (Pubitemid 29467153)
32. Moustafa AA, Sherman SJ, & Frank MJ (2008) A dopaminergic basis for working memory, learning and attentional shifting in Parkinsonism. Neuropsychologia, 46, 3144-3156
33. Muslimovic D, Post B, Speelman JD, de Haan RJ,&Schmand B(2009) Cognitive decline in Parkinson's disease:Aprospective longitudinal study. J Int Neuropsychol Soc, 15, 426-437
34. Muller U,Wachter T, Barthel H, Reuter M,&von CramonDY (2000) Striatal [123I]beta-CIT SPECT and prefrontal cognitive functions in Parkinson's disease. J Neural Transm, 107, 303-319 (Pubitemid 30162692)
35. Nobili F, Campus C, Arnaldi D, De CF, Cabassi G, Brugnolo A, et al. (2010) Cognitive-nigrostriatal relationships in de novo, drug-naive Parkinson's disease patients: A [I-123]FPCIT SPECT study. Mov Disord, 25, 35-43
36. Frank MJ, Loughry B, & O'Reilly RC (2001) Interactions between frontal cortex and basal ganglia in working memory: A computational model. Cogn Affect Behav Neurosci, 1, 137-160 (Pubitemid 38392490)
37. Colzato LS, Slagter HA, de RM, & Hommel B (2011) Dopamine and the management of attentional resources: Genetic markers of striatal D2 dopamine predict individual differences in the attentional blink. JCogn Neurosci, 23, 3576-3585
38. Slagter HA, Tomer R, Christian BT, Fox AS, Colzato LS, King CR, et al. (2012) PET evidence for a role for striatal dopamine in the attentional blink: Functional implications. J Cogn Neurosci, 24, 1932-1940
39. Schneider JS (1984) Basal ganglia role in behavior: Importance of sensory gating and its relevance to psychiatry. Biol Psychiatry, 19, 1693-1710 (Pubitemid 15196114)
40. Giakoumaki SG, Bitsios P, & Frangou S (2006) The level of prepulse inhibition in healthy individuals may index cortical modulation of early information processing. Brain Res, 1078, 168-170
41. Freudenberg F, Dieckmann M,Winter S,Koch M,&Schwabe K (2007) Selective breeding for deficient sensorimotor gating is accompanied by increased perseveration in rats. Neuroscience, 148, 612-622 (Pubitemid 47418380)
42. Darcourt J, Booij J, Tatsch K, Varrone A, Vander BT, Kapucu OL, et al. (2010) EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging 37, 443-450
43. Backman L, Robins-Wahlin TB, Lundin A, Ginovart N, & Farde L (1997) Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes. Brain, 120(Pt 12), 2207-2217 (Pubitemid 28014597)
44. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, et al. (2001) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry, 158, 377-382 (Pubitemid 32205193)
45. Nelson HE,&O'Connell A (1978) Dementia: The estimation of premorbid intelligence levels using the NewAdult Reading Test. Cortex, 14, 234-244 (Pubitemid 8386900)
46. Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, & Hodges JR (2000)Abrief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology, 55, 1613-1620
47. Bitsios P, & Giakoumaki SG (2005) Relationship of prepulse inhibition of the startle reflex to attentional and executive mechanisms in man. Int J Psychophysiol, 55, 229-241 (Pubitemid 40093104)
48. Bitsios P, Giakoumaki SG, Theou K, & Frangou S (2006) Increased prepulse inhibition of the acoustic startle response is associated with better strategy formation and execution times in healthy males. Neuropsychologia, 44, 2494-2499 (Pubitemid 44062565)
49. Csomor PA, Stadler RR, Feldon J, Yee BK, Geyer MA, & Vollenweider FX (2008) Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology 33, 497-512
50. Ralph RJ, Paulus MP, Fumagalli F, Caron MG, & Geyer MA (2001) Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: Differential effects of D1 and D2 receptor antagonists. J Neurosci, 21, 305-313 (Pubitemid 32098754)
51. Yukawa K, Tanaka T, Owada-Makabe K, Tsubota Y, Bai T, Maeda M, et al. (2005) Reduced prepulse inhibition of startle in STAT6-deficient mice. Int J Mol Med, 16, 673-675
52. Powell SB, Young JW, Ong JC, Caron MG, & Geyer MA (2008) Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice. Behav Pharmacol, 19, 562-565
53. Sacchetti P, Mitchell TR, Granneman JG, & Bannon MJ (2001) Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism. J Neurochem, 76, 1565-1572 (Pubitemid 32198260)
54. Bannon MJ, Michelhaugh SK, Wang J, & Sacchetti P (2001) The human dopamine transporter gene: Gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders. Eur Neuropsychopharmacol 11, 449-455 (Pubitemid 33026519)
55. Le WD, Xu P, Jankovic J, Jiang H, Appel SH, Smith RG, & Vassilatis DK (2003) Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet 33, 85-89 (Pubitemid 36068688)
56. Rinne JO, Portin R, Ruottinen H, Nurmi E, Bergman J, Haaparanta M, & Solin O (2000) Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study. Arch Neurol 57, 470-475 (Pubitemid 30212118)
57. Ancin I, Cabranes JA, Vazquez-Alvarez B, Santos JL, Sanchez-Morla E, Alaerts M, et al. (2012) NR4A2: Effects of an "Orphan" Receptor on Sustained Attention in a Schizophrenic Population. Schizophr Bull 39(3) 555-563
58. O'ReillyRC(2006) Biologically based computational models of high-level cognition. Science, 314, 91-94
59. Tan HY, Chen Q, Goldberg TE, Mattay VS, Meyer- Lindenberg A, Weinberger DR, & Callicott JH (2007) Catechol-O-methyltransferase Val158Met modulation of prefrontal-parietal-striatal brain systems during arithmetic and temporal transformations inworking memory. J Neurosci, 27, 13393-13401 (Pubitemid 350255332)
60. Braver TS, & Cohen JD (1999) Dopamine, cognitive control, and schizophrenia: The gating model. Prog Brain Res, 121, 327-349 (Pubitemid 29457058)
61. Cools R, & D'Esposito M (2011) Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry, 69, e113-e125
62. Fry AF, & Hale S (2000) Relationships among processing speed, working memory, and fluid intelligence in children. Biol Psychol, 54, 1-34
63. Frank MJ, Loughry B, & O'Reilly RC (2001) Interactions between frontal cortex and basal ganglia in working memory: A computational model. Cogn Affect Behav Neurosci, 1, 137-160 (Pubitemid 38392490)
64. Gruber AJ, Dayan P, Gutkin BS,&SollaSA(2006) Dopamine modulation in the basal ganglia locks the gate to working memory. J Comput Neurosci, 20, 153-166
65. Medan V, & Preuss T (2011) Dopaminergic-induced changes in Mauthner cell excitability disrupt prepulse inhibition in the startle circuit of goldfish. J Neurophysiol, 106, 3195-3204
66. Braff D, Stone C, Callaway E, Geyer M, Glick I, & Bali L (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology, 15, 339-343 (Pubitemid 9016401)
67. Leumann L, Feldon J, Vollenweider FX,&Ludewig K (2002) Effects of typical and atypical antipsychotics on prepulse inhibition and latent inhibition in chronic schizophrenia. Biol Psychiatry 52, 729-739
68. Cromwell HC, Klein A, & Mears RP (2007) Single unit and population responses during inhibitory gating of striatal activity in freely moving rats. Neuroscience, 146, 69-85 (Pubitemid 46654621)
69. Forstmann BU, Dutilh G, Brown S, Neumann J, von Cramon DY, Ridderinkhof KR, & Wagenmakers EJ (2008) Striatum and pre-SMA facilitate decision-making under time pressure. Proc Natl Acad Sci U S A, 105, 17538-17542
70. Sawamoto N, Honda M, Hanakawa T, Fukuyama H, & Shibasaki H (2002) Cognitive slowing in Parkinson's disease: A behavioral evaluation independent of motor slowing. J Neurosci, 22, 5198-5203 (Pubitemid 37465632)
71. Bachmann T, Asser T, Sarv M, Taba P, Lausvee E, Poder E, et al. (1998) Speed of elementary visual recognition operations in Parkinson's disease as measured by the mutual masking method. J Clin Exp Neuropsychol, 20, 118-134 (Pubitemid 28318065)
72. Sawamoto N, Honda M, HanakawaT, AsoT, Inoue M,Toyoda H, et al. (2007) Cognitive slowing in Parkinson disease is accompanied by hypofunctioning of the striatum. Neurology, 68, 1062-1068. (Pubitemid 46569143)